ロード中...
Tolvaptan-induced hypernatremia related to low serum potassium level accompanying high blood pressure in patients with acute decompensated heart failure
BACKGROUNDS: Tolvaptan significantly increases urine volume in acute decompensated heart failure (ADHF); serum sodium level increases due to aquaresis in almost all cases. We aimed to elucidate clinical factors associated with hypernatremia in ADHF patients treated with tolvaptan. METHODS: We enroll...
保存先:
| 出版年: | BMC Cardiovasc Disord |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7597047/ https://ncbi.nlm.nih.gov/pubmed/33121430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-020-01751-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|